Senior Group Leader

Research Group Home Page: 

Work address: 
Professor Sir Bruce Ponder will no longer consider applications from graduate students or interns to join his research team. If you email to request such a study opportunity, unfortunately, you will not receive a reply. Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE
Publications: 

RTNduals: An R/Bioconductor package for analysis of co-regulation and inference of dual regulons.

E-pub date: 31 May 2019


RTNsurvival : An R/Bioconductor package for regulatory network survival analysis.

E-pub date: 28 Feb 2019


A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma.

E-pub date: 28 Feb 2019


Raman micro-spectroscopy for accurate identification of primary human bronchial epithelial cells.

E-pub date: 31 Jul 2018


ERα Binding by Transcription Factors NFIB and YBX1 Enables FGFR2 Signaling to Modulate Estrogen Responsiveness in Breast Cancer.

E-pub date: 15 Jan 2018


BaalChIP: Bayesian analysis of allele-specific transcription factor binding in cancer genomes.

E-pub date: 24 Feb 2017


FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness.

E-pub date: 31 Aug 2016


Identification of Post-Transcriptional Modulators of Breast Cancer Transcription Factor Activity Using MINDy.

E-pub date: 31 Aug 2016


Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies.

E-pub date: 31 May 2016


Regulators of genetic risk of breast cancer identified by integrative network analysis.

E-pub date: 31 Jan 2016


Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.

E-pub date: 08 Jan 2015


Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.

E-pub date: 05 Dec 2013


TOX3 mutations in breast cancer.

E-pub date: 31 Aug 2013


Master regulators of FGFR2 signalling and breast cancer risk.

E-pub date: 31 Aug 2013


Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.

E-pub date: 04 Apr 2013


The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis.

E-pub date: 01 Feb 2013


Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B.

E-pub date: 31 Aug 2012


The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene.

E-pub date: 01 Aug 2012


Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression.

E-pub date: 01 Jul 2012


RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation.

E-pub date: 01 Jun 2012


Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers.

E-pub date: 18 Apr 2012


Allele-specific expression analysis methods for high-density SNP microarray data.

E-pub date: 15 Apr 2012


Genome-wide association analysis identifies three new breast cancer susceptibility loci.

E-pub date: 22 Jan 2012


The histone demethylase JMJD2B plays an essential role in human carcinogenesis through positive regulation of cyclin-dependent kinase 6.

E-pub date: 31 Dec 2011


Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway.

E-pub date: 01 Oct 2011


Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1.

E-pub date: 31 Aug 2011


Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker.

E-pub date: 31 Jul 2011


A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.

E-pub date: 31 Jul 2011


Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer.

E-pub date: 28 May 2011


Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers.

E-pub date: 01 Feb 2011


Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers.

E-pub date: 01 Feb 2011


Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells.

E-pub date: 01 Feb 2011


No association between TERT-CLPTM1L single nucleotide polymorphism rs401681 and mean telomere length or cancer risk.

E-pub date: 31 Jul 2010


Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.

E-pub date: 15 Jul 2010


Fine scale mapping of the breast cancer 16q12 locus.

E-pub date: 15 Jun 2010


Telomere length in prospective and retrospective cancer case-control studies.

E-pub date: 15 Apr 2010


Common germ-line polymorphism of C1QA and breast cancer survival.

E-pub date: 13 Apr 2010


Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway.

E-pub date: 13 Mar 2010


Cohort Profile: The Golestan Cohort Study–a prospective study of oesophageal cancer in northern Iran.

E-pub date: 01 Feb 2010


Personalized genomic information: preparing for the future of genetic medicine.

E-pub date: 01 Feb 2010


A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.

E-pub date: 01 Sep 2009


Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast.

E-pub date: 31 Aug 2009


UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer.

E-pub date: 07 Jul 2009


Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study.

E-pub date: 15 Jun 2009


Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.

E-pub date: 31 May 2009


FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation.

E-pub date: 01 May 2009


Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer.

E-pub date: 24 Mar 2009


Association of ESR1 gene tagging SNPs with breast cancer risk.

E-pub date: 15 Mar 2009


Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer.

E-pub date: 31 Jan 2009


Identification of common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal women.

E-pub date: 31 Dec 2008


Hyaluronan-mediated motility receptor gene single nucleotide polymorphisms and risk of breast cancer.

E-pub date: 31 Dec 2008


Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk.

E-pub date: 31 Dec 2008


Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer.

E-pub date: 01 Nov 2008


Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients.

E-pub date: 31 Oct 2008


The effects of common genetic variants in oncogenes on ovarian cancer survival.

E-pub date: 15 Sep 2008


Breast Cancer Research–the first ten years.

E-pub date: 31 Aug 2008


Risk factors for the incidence of breast cancer: do they affect survival from the disease?

E-pub date: 10 Jul 2008


Multiple loci with different cancer specificities within the 8q24 gene desert.

E-pub date: 02 Jul 2008


Polygenes, risk prediction, and targeted prevention of breast cancer.

E-pub date: 26 Jun 2008


Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.

E-pub date: 06 May 2008


Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.

E-pub date: 25 Apr 2008


Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.

E-pub date: 01 Feb 2008


Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer.

E-pub date: 31 Dec 2007


Association study of 69 genes in the ret pathway identifies low-penetrance loci in sporadic medullary thyroid carcinoma.

E-pub date: 01 Oct 2007


Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk.

E-pub date: 31 Aug 2007


Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.

E-pub date: 20 Jul 2007


Genome-wide association study identifies novel breast cancer susceptibility loci.

E-pub date: 28 Jun 2007


Screening for the BRCA1-ins6kbEx13 mutation: potential for misdiagnosis. Mutation in brief #964. Online.

E-pub date: 31 May 2007


Rat Mcs5a is a compound quantitative trait locus with orthologous human loci that associate with breast cancer risk.

E-pub date: 10 Apr 2007


Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer.

E-pub date: 01 Apr 2007


A common coding variant in CASP8 is associated with breast cancer risk.

E-pub date: 31 Mar 2007


Association between common variation in 120 candidate genes and breast cancer risk.

E-pub date: 16 Mar 2007


Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer.

E-pub date: 07 Mar 2007


CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.

E-pub date: 01 Jun 2004


Polymorphisms associated with circulating sex hormone levels in postmenopausal women.

E-pub date: 31 May 2004


Novel human, mouse and xenopus genes encoding a member of the RAS superfamily of low-molecular-weight GTP-binding proteins and its downregulation in W/WV mouse jejunum.

E-pub date: 01 Feb 2004


EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.

E-pub date: 31 Oct 2003


Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.

E-pub date: 01 Jan 2003


Variants in DNA double-strand break repair genes and breast cancer susceptibility.

E-pub date: 31 May 2002


Sex differences in sex chromosome gene expression in mouse brain.

E-pub date: 31 May 2002


DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis.

E-pub date: 30 Nov 2001


Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk.

E-pub date: 01 Nov 2001


The Drosophila Ret gene is transcribed in multiple alternatively spliced forms.

E-pub date: 01 Oct 2000


Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group.

E-pub date: 01 Sep 2000


Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers.

E-pub date: 31 Jul 2000


Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.

E-pub date: 30 Jun 2000


Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer.

E-pub date: 30 Jun 2000


Idiopathic slow-transit constipation is not associated with mutations of the RET proto-oncogene or GDNF.

E-pub date: 01 Jun 2000


Familial predisposition to breast cancer in a British population: implications for prevention.

E-pub date: 01 Apr 2000


Comparison of DNA repair protein expression and activities between human fibroblast cell lines with different radiosensitivities.

E-pub date: 29 Feb 2000


Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk.

E-pub date: 01 Feb 2000


A case of inv dup(8p) with early onset breast cancer.

E-pub date: 01 Jan 2000


No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer.

E-pub date: 01 Nov 1999


National Confidential Enquiry into counselling for genetic disorders by non-geneticists: general recommendations and specific standards for improving care.

E-pub date: 01 Jul 1999


Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2.

E-pub date: 01 Jul 1999


Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations.

E-pub date: 01 May 1999


Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group.

E-pub date: 31 Mar 1999


Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

E-pub date: 31 Jul 1998


No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer.

E-pub date: 01 Jun 1998


Clues to the function of the tumour susceptibility gene BRCA2.

E-pub date: 01 Jun 1998


Mutation analysis of the c-mos proto-oncogene in human ovarian teratomas.

E-pub date: 01 May 1998


A systematic review and meta-analysis of family history and risk of ovarian cancer.

E-pub date: 01 May 1998


Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay.

E-pub date: 01 May 1998


Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

E-pub date: 01 Mar 1998


First continuous human pheochromocytoma cell line: KNA. Biological, cytogenetic and molecular characterization of KNA cells.

E-pub date: 01 Mar 1998


Involvement of Brca2 in DNA repair.

E-pub date: 01 Feb 1998


Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers.

E-pub date: 01 Jan 1998


Genetic testing for cancer risk.

E-pub date: 31 Oct 1997


Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.

E-pub date: 01 Jul 1997


Cancer genes and molecular oncology in the clinic.

E-pub date: 01 May 1997


Family history and the risk of breast cancer: a systematic review and meta-analysis.

E-pub date: 30 Apr 1997


Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population.

E-pub date: 01 Feb 1997


Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas.

E-pub date: 01 Nov 1996


Mutation screening of MSH2 and MLH1 mRNA in hereditary non-polyposis colon cancer syndrome.

E-pub date: 01 Sep 1996


Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.

E-pub date: 31 Aug 1996


RET oncogene.

E-pub date: 01 Feb 1996


Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.

E-pub date: 01 Dec 1995


No mutation at codon 918 of the RET gene in a family with multiple endocrine neoplasia type 2B.

E-pub date: 01 Dec 1995


Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.

E-pub date: 01 Nov 1995


Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium.

E-pub date: 01 Oct 1995


Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene.

E-pub date: 01 Sep 1995


Molecular genetics of familial breast-ovarian cancer.

E-pub date: 01 Sep 1995


Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease.

E-pub date: 31 Aug 1995


Genetic testing of the common cancers: potential and problems.

E-pub date: 01 Aug 1995


Genetic testing in breast/ovarian cancer (BRCA1) families.

E-pub date: 31 Jul 1995


Ordering of markers in the pericentromeric region of chromosome 10.

E-pub date: 01 Jul 1995


Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.

E-pub date: 01 Jul 1995


A gene (DLG2) located at 17q12-q21 encodes a new homologue of the Drosophila tumor suppressor dIg-A.

E-pub date: 30 Jun 1995


Genetic linkage analysis in hereditary non-polyposis colon cancer syndrome.

E-pub date: 01 May 1995


A frequent hMSH2 mutation in hereditary non-polyposis colon cancer syndrome.

E-pub date: 28 Feb 1995


A matched control study of familial epithelial ovarian cancer: patient characteristics, response to chemotherapy and outcome.

E-pub date: 01 Jan 1995


Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene.

E-pub date: 01 Dec 1994


De-novo mutations of the RET proto-oncogene in Hirschsprung’s disease.

E-pub date: 30 Nov 1994


A novel polymorphism in the coding sequence of the human RET proto-oncogene.

E-pub date: 01 Nov 1994


Haplotype analysis of MEN 2 mutations.

E-pub date: 01 Oct 1994


Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

E-pub date: 31 Aug 1994


Long segment and short segment familial Hirschsprung’s disease: variable clinical expression at the RET locus.

E-pub date: 31 Aug 1994


A 7 bp deletion of the RET proto-oncogene in familial Hirschsprung’s disease.

E-pub date: 31 Aug 1994


Setting up and running a familial cancer clinic.

E-pub date: 01 Jul 1994


Presymptomatic screening for medullary thyroid carcinoma in patients with multiple endocrine neoplasia type 2A.

E-pub date: 01 Jul 1994


Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy?

E-pub date: 01 Jun 1994


A de novo mutation of the RET proto-oncogene in a patient with MEN 2A.

E-pub date: 01 Jun 1994


The gene causing multiple endocrine neoplasia type 2 (MEN 2).

E-pub date: 01 Jun 1994


Direct, non-radioactive detection of mutations in multiple endocrine neoplasia type 2A families.

E-pub date: 01 Apr 1994


Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.

E-pub date: 01 Apr 1994


Human familial and sporadic breast cancer: analysis of the coding regions of the 17 beta-hydroxysteroid dehydrogenase 2 gene (EDH17B2) using a single-strand conformation polymorphism assay.

E-pub date: 01 Mar 1994


A multiple interval physical map of the pericentromeric region of human chromosome 10.

E-pub date: 01 Mar 1994


Familial cancer syndromes.

E-pub date: 28 Feb 1994


Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

E-pub date: 28 Feb 1994


Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.

E-pub date: 01 Feb 1994


Familial breast cancer.

E-pub date: 31 Dec 1993


The organisation of repetitive sequences in the pericentromeric region of human chromosome 10.

E-pub date: 30 Nov 1993


Absence of linkage to the ataxia telangiectasia locus in familial breast cancer.

E-pub date: 31 Aug 1993


The role of gene mutations in the genesis of familial cancers.

E-pub date: 01 Jul 1993


Localisation of the gene for multiple endocrine neoplasia type 2A to a 480 kb region in chromosome band 10q11.2.

E-pub date: 01 Mar 1993


Genetic linkage studies map the multiple endocrine neoplasia type 2 loci to a small interval on chromosome 10q11.2.

E-pub date: 01 Mar 1993


Duplicated KOX zinc finger gene clusters flank the centromere of human chromosome 10: evidence for a pericentric inversion during primate evolution.

E-pub date: 28 Feb 1993


Dinucleotide repeat polymorphisms at the D10S183 and D10S245 loci.

E-pub date: 01 Dec 1992


Complete characterization of a large marker chromosome by reverse and forward chromosome painting.

E-pub date: 01 Dec 1992


Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.

E-pub date: 30 Nov 1992


Early diagnosis of the multiple endocrine neoplasia type 2 syndrome: consensus statement. European Community Concerted Action: Medullary Thyroid Carcinoma.

E-pub date: 01 Nov 1992


TaqI polymorphisms at the annexin VIII locus (ANX8).

E-pub date: 01 Oct 1992


An SphI polymorphism at the ZNF22 locus.

E-pub date: 01 Oct 1992


An SphI polymorphism at the vinculin locus (VCL).

E-pub date: 01 Oct 1992


Dinucleotide repeat polymorphism at the RBP3 locus in chromosome band 10q11.2.

E-pub date: 01 Sep 1992


Characterisation of a boundary between satellite III and alphoid sequences on human chromosome 10.

E-pub date: 31 Aug 1992


Complementary physical and genetic techniques map the vinculin (VCL) gene on chromosome 10q.

E-pub date: 31 Aug 1992


Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer.

E-pub date: 01 Jul 1992


A cluster of expressed zinc finger protein genes in the pericentromeric region of human chromosome 10.

E-pub date: 01 Jul 1992


Genetic heterogeneity of early-onset familial breast cancer.

E-pub date: 01 Jun 1992


Molecular genetics of cancer.

E-pub date: 30 Apr 1992


Linkage mapping of human chromosome 10 microsatellite polymorphisms.

E-pub date: 01 Mar 1992


Genetic susceptibility to naevi–a twin study.

E-pub date: 01 Dec 1991


Localization of the human O6-methylguanine-DNA methyltransferase gene to chromosome 10q24.33-qter.

E-pub date: 01 Oct 1991


A new polymorphism in the ret protooncogene (RET).

E-pub date: 30 Sep 1991


A BglII polymorphism in the human NF1 gene.

E-pub date: 31 Aug 1991


Genetic predisposition to cancer.

E-pub date: 31 Aug 1991


The gene for von Recklinghausen neurofibromatosis (NF1) maps to the pericentromeric region of chromosome 17 in Chinese families.

E-pub date: 31 Aug 1991


Establishment of a European registry for familial ovarian cancer.

E-pub date: 01 Aug 1991


Towards improved cancer diagnosis and treatment founded on current developments in the basic sciences: options for intensified European efforts. An EORTC Research Branch Scientific Advisory Board Consensus Paper.

E-pub date: 01 Aug 1991


Genetics and cancer.

E-pub date: 01 Aug 1991


A TaqI polymorphism in the human NF1 gene.

E-pub date: 31 Jul 1991


A BamHI polymorphism in the human EVI2A gene (human homolog of the murine gene Evi-2).

E-pub date: 30 Apr 1991


Breast cancer genes.

E-pub date: 31 Mar 1991


Hereditary ovarian cancer. Heterogeneity in age at diagnosis.

E-pub date: 28 Feb 1991


Presymptomatic screening for multiple endocrine neoplasia type 2A with linked DNA markers. The MEN 2A International Collaborative Group.

E-pub date: 31 Dec 1990


Mapping of von Hippel-Lindau disease to chromosome 3p confirmed by genetic linkage analysis.

E-pub date: 01 Dec 1990


Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2A.

E-pub date: 01 Oct 1990


Genetic and physical map of the von Recklinghausen neurofibromatosis (NF1) region on chromosome 17.

E-pub date: 01 Sep 1990


Inherited predisposition to cancer.

E-pub date: 01 Jul 1990


Regional localization of polymorphic markers on chromosome 10 by physical and genetic mapping.

E-pub date: 01 May 1990


CT scanning as an adjunct to screening for medullary carcinoma of the thyroid.

E-pub date: 01 Mar 1990


Multiple endocrine neoplasia type 2.

E-pub date: 31 Jan 1990


Effect of gamma radiation at high- and low-dose rate on a novel in vivo mutation assay in mouse intestine.

E-pub date: 01 Sep 1989


Early diagnosis of multiple endocrine neoplasia type IIa.

E-pub date: 31 Aug 1989


Linked markers flanking the gene for multiple endocrine neoplasia type 2A.

E-pub date: 31 Aug 1989


Polyclonal origin of mouse skin papillomas.

E-pub date: 01 Jul 1989


Progress towards identifying the neurofibromatosis (NF1) gene.

E-pub date: 01 Jul 1989


Development of multiple endocrine neoplasia type 2A does not involve substantial deletions of chromosome 10.

E-pub date: 01 Apr 1989


BclI RFLP for the human vimentin gene.

E-pub date: 31 Aug 1988


Neurofibromatosis.

E-pub date: 31 Jul 1988


The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients.

E-pub date: 01 Feb 1988


Styl RFLP recognised by a human IRBP cDNA localised to chromosome 10.

E-pub date: 31 Jan 1988


Risk estimation and screening in families of patients with medullary thyroid carcinoma.

E-pub date: 31 Jan 1988


Linkage of NF1 to 12 chromosome 17 markers: a summary of eight concurrent reports.

E-pub date: 01 Dec 1987


Tightly linked markers for the neurofibromatosis type 1 gene.

E-pub date: 01 Dec 1987


Genetic analysis of NF1: identification of close flanking markers on chromosome 17.

E-pub date: 01 Dec 1987


Linkage analysis of British and Indian families with Von Recklinghausen neurofibromatosis.

E-pub date: 01 Sep 1987


Immunohistochemical study of calcitonin gene-related peptide in human medullary carcinoma and C cell hyperplasia.

E-pub date: 01 Jul 1987


Calculating numbers of tissue progenitor cells using chimaeric animals.

E-pub date: 01 May 1987


Immunohistochemistry in the analysis of mouse aggregation chimaeras.

E-pub date: 01 May 1986


The gene controlling the binding sites of Dolichos biflorus agglutinin, Dlb-1, is on chromosome 11 of the mouse.

E-pub date: 01 Apr 1986


Oncogenes and bladder cancer.

E-pub date: 01 Dec 1985


Medullary carcinoma of the thyroid. An immunocytochemical and histochemical study of 25 cases using eight separate markers.

E-pub date: 31 Oct 1985


Sequential methotrexate and 5-fluorouracil in the treatment of non-small cell carcinoma of the lung.

E-pub date: 01 May 1985


Cell migration pathway in the intestinal epithelium: an in situ marker system using mouse aggregation chimeras.

E-pub date: 01 Feb 1985


Derivation of mouse intestinal crypts from single progenitor cells.

E-pub date: 31 Jan 1985


Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.

E-pub date: 01 Dec 1984


Chemotherapy of diffuse malignant mesothelioma. Phase II trials of single-agent 5-fluorouracil and adriamycin.

E-pub date: 31 Aug 1984


Phase II study of VP 16-213 (etoposide) in metastatic transitional cell urothelial cancer.

E-pub date: 01 Aug 1984


Clinical implications of current studies in carcinogenesis.

E-pub date: 01 Aug 1984


Potential value of antisera to epithelial membrane antigen in detecting early invasion in transitional cell carcinoma.

E-pub date: 01 Dec 1983


Organ-related differences in binding of Dolichos biflorus agglutinin to vascular endothelium.

E-pub date: 01 Apr 1983


Prognostic factors in non-infiltrating carcinoma of the bladder: a preliminary report.

E-pub date: 01 Dec 1982


Looking for genomic changes in cancer cells.

E-pub date: 31 Aug 1981


Tetany associated with cis-platin.

E-pub date: 30 Nov 1980


Genetics and cancer.

E-pub date: 31 Oct 1980


Is pancreatic isotope scanning worthwhile?

E-pub date: 31 Jan 1978


The arrangement of nucleosomes in nucleoprotein complexes from polyoma virus and SV40.

E-pub date: 01 May 1977


Complete heart block in patients with peroneal muscular atrophy.

E-pub date: 01 Sep 1971


Show all